This article is more than 5 years old. Information may no longer be current.
IOL sets new standard for efficiency, safety, predictability
Click Here to Manage Email Alerts
ROME — An IOL offers all the advantages of a no-touch lens implantation procedure and easy, smooth unfolding, according to a surgeon speaking here.
The Hoya iSert 251 has received a CE mark in Europe and is now under evaluation by the U.S. Food and Drug Administration.
"In my practice in Munich, Germany, I use it exclusively," Kenneth R. Kenyon, MD, said at the annual joint meeting of Ocular Surgery News and the Italian Society of Ophthalmology. "The quality of the aspheric optics is superb. It has no glistening and patients are happy with their vision."
The lens comes pre-loaded in a dedicated inserter, providing a closed system that reduces lens damage and assures sterility.
"There is no manipulation, no risk of damaging the lens, no risk of contamination or toxic anterior segment syndrome," Dr. Kenyon said.
The lens material is acrylic, while the tips are blue PMMA. The color allows visualization of the haptics and the material enhances spontaneous unfolding.
"When you inject acrylic lenses, the haptics tend to get stuck to the optic and need manipulation. The PMMA tips don't stick and unfold spontaneously. ... There is no need to push and pull and spin it," Dr. Kenyon said.
He has implanted the lens in about 50 eyes, 30 of which are included in the FDA trial.
- Disclosure: Dr. Kenyon is a consultant for Hoya Surgical Optics.